Class II · Moderate riskTerminated Initiated May 1, 2012 (14 years ago)
Octreotide Acetate Injection, 50 mcg/mL (0.05 mg/mL), 1 mL single dose vials, packaged in…
Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.
Why it was recalled
Short Fill: These products are being recalled because there is potential that vials with low fill volume were released into distribution.
What was recalled
Octreotide Acetate Injection, 50 mcg/mL (0.05 mg/mL), 1 mL single dose vials, packaged in 10 x 1 mL single dose vials per pack, Rx only, Manufactured for: Bedford Laboratories, Bedford, OH 44146; Manufactured by: Ben Venue Laboratories, Inc., Bedford, OH 44146; NDC 55390-160-10; UPC 3 55390-160-10 1.
Recalling firm
Ben Venue Laboratories Inc
NDC code
55390-160-10
Origin
OH, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1377-2012
What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.
Reason Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the…
Reason Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the…
Teva Pharmaceuticals USA, IncNDC 0480-9262-08D-0406-2026
Reason Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the…
Teva Pharmaceuticals USA, IncNDC 0480-9259-08D-0405-2026
Reason Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food and Drug Administration (FDA) inspection at the…
Teva Pharmaceuticals USA, IncNDC 0480-9257-08D-0404-2026